Unleashing the Power of Gene Therapy

Reimagining Gene Therapy

Kriya is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. We aim to revolutionize how gene therapies are designed, developed and manufactured – improving speed to market and delivering significant reductions in the cost per dose. Using our computationally enabled platform for rational vector design, SIRVE™, and our high-efficiency manufacturing platform, STRIPE™, we are advancing a deep and diversified pipeline of innovative gene therapies spanning rare and prevalent diseases in multiple therapeutic areas.

We believe that rationally engineered and manufactured gene therapies can transform the treatment of a broad universe of diseases – and we are prepared to lead this revolution in medicine.

Our Technology

SIRVE™ is our proprietary computationally-enabled platform for rational vector design, sequence modification, and data analysis. We are deploying SIRVE to advance a pipeline of gene therapies addressing a range of diseases.

Our Team

We have deep expertise in the field of gene therapy, with a team of pioneering veterans who have decades of experience at leading gene therapy companies and academic institutions

Manufacturing

Our proprietary high-efficiency manufacturing platform, STRIPE™, integrates the latest advances in cell line technology and process sciences. We are developing STRIPE at our 51,000 square foot manufacturing facility located in Research Triangle Park, North Carolina, one of the global centers for manufacturing in the biologics industry – with a goal of supporting the modular production of gene therapies at larger scale and substantially lower cost than current industry norms in gene therapy.

Top Talent in Top Locations

BAY AREA
California

RESEARCH TRIANGLE PARK
North Carolina

Investors 

Transhuman Capital logo
QVT Financial LP logo
Dexcel Pharma Logo
Forsite Capital logo
JDRF T1D Fund logo
Transhuman Capital logo
JDRF T1D Fund logo
BlueBird Ventures Logo

Amplo Logo
Transhuman Capital logo
JDRF T1D Fund logo

Be a Part of the Future of Gene Therapy